放射線療法の世界市場見通し2016-2022

◆英語タイトル:Radiotherapy - Global Market Outlook (2016-2022)
◆商品コード:SMRC60949
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年8月
◆ページ数:121
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、放射線療法の世界市場について調査・分析し、放射線療法の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・放射線療法の世界市場:市場動向分析
・放射線療法の世界市場:競争要因分析
・放射線療法の世界市場:装置別分析/市場規模
・放射線療法の世界市場:技術別分析/市場規模
・放射線療法の世界市場:製品種類別分析/市場規模
・放射線療法の世界市場:用途別分析/市場規模
・放射線療法の世界市場:地域別分析/市場規模
・放射線療法の北米市場規模
・放射線療法の欧州市場規模
・放射線療法のアジア市場規模
・放射線療法の世界市場:主な市場開拓
・関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Radiotherapy Market is accounted for $6.5 billion in 2015 and is expected to reach $10.2 billion by 2022 growing at a CAGR of 6.6% during the forecast period. Rising number of cancer patients, technological advancements and increasing aging population are some of the key factors fueling the market growth. However, lack of sufficient infrastructure and healthcare costs are expected to hinder the market.

Technologies such as External beam radiotherapy and internal beam radiotherapy are anticipated to witness highest growth owing to increased pool of cancer patients. North America commanded the largest market share as it is constantly inclined to the newer technologies when compared to slow-moving markets such as Europe. Rising incidence of cancer and unmet healthcare needs in APAC provides ample of opportunities for the players in the market over the foreseeable future.

Some of the key players in the market include Siemens Healthcare, GE Healthcare, Nordion, Inc., IBA Group, Angiodynamics Inc, Ion Beam Applications SA, Protom International Inc, IsoRay Medical, Inc., Coviden Plc, Varian Medical Systems Inc, Accuray Inc, Mevion Medical Systems, Inc, C.R. BARD Inc, CIVCO Medical Solutions, Mitsubishi Electric Corporation, Brainlab AG, RaySearch Laboratories AB, Elekta AB and Nanobiotix.

Equipments Covered:
• Linear Accelerators
o Treatment Planning Systems
o Radiation Therapy Simulators

Technologies Covered:
• Internal radiation therapy
o High Dose Rate Radiotherapy
o Low-Dose Rate Radiotherapy
• Systemic radiation therapy
• External Beam Radiation Therapy
o Stereotactic body radiation therapy
o Intensity-modulated radiation therapy (IMRT)
o 3D-Conformal Radiotherapy (3D-CRT)
o Tomotherapy
o Volumetric Modulated ARC Therapy
o Image-guided radiation therapy (IGRT)
o Proton Beam therapy
o Stereotactic radiosurgery

Product Types Covered:
• Electron Beams
• Non-Ionizing Radiation
• Photon Radiations
• Ionizing Radiation
• Alpha and Beta Particles
• Particle Radiation
• Neutron Beams
• Gamma Rays
• X-rays
• Proton Beams
• Carbon Ions

Applications Covered:
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Spine Cancer
• Cervical Cancer
• Penile Cancer
• Gynaecological Cancer
• Skin & Lip Cancer
• Lung Cancer
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Radiotherapy Market, By Equipment
5.1 Introduction
5.2 Linear Accelerators
5.2.1 Treatment Planning Systems
5.2.2 Radiation Therapy Simulators

6 Global Radiotherapy Market, By Technology
6.1 Introduction
6.2 Internal radiation therapy
6.2.1 High Dose Rate Radiotherapy
6.2.2 Low-Dose Rate Radiotherapy
6.3 Systemic radiation therapy
6.4 External Beam Radiation Therapy
6.4.1 Stereotactic body radiation therapy
6.4.2 Intensity-modulated radiation therapy (IMRT)
6.4.3 3D-Conformal Radiotherapy (3D-CRT)
6.4.4 Tomotherapy
6.4.5 Volumetric Modulated ARC Therapy
6.4.6 Image-guided radiation therapy (IGRT)
6.4.7 Proton Beam therapy
6.4.8 Stereotactic radiosurgery

7 Global Radiotherapy Market, By Product Type
7.1 Introduction
7.2 Electron Beams
7.3 Non-Ionizing Radiation
7.4 Photon Radiations
7.5 Ionizing Radiation
7.6 Alpha and Beta Particles
7.7 Particle Radiation
7.8 Neutron Beams
7.9 Gamma Rays
7.10 X-rays
7.11 Proton Beams
7.12 Carbon Ions

8 Global Radiotherapy Market, By Application
8.1 Introduction
8.2 Head and Neck Cancer
8.3 Breast Cancer
8.4 Prostate Cancer
8.5 Colorectal Cancer
8.6 Spine Cancer
8.7 Cervical Cancer
8.8 Penile Cancer
8.9 Gynaecological Cancer
8.10 Skin & Lip Cancer
8.11 Lung Cancer
8.12 Other Applications

9 Global Radiotherapy Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Siemens Healthcare
11.2 GE Healthcare
11.3 Nordion, Inc.
11.4 IBA Group
11.5 Angiodynamics Inc
11.6 Ion Beam Applications SA
11.7 Protom International Inc
11.8 IsoRay Medical, Inc.
11.9 Coviden Plc
11.10 Varian Medical Systems Inc
11.11 Accuray Inc
11.12 Mevion Medical Systems, Inc
11.13 C.R. BARD Inc
11.14 CIVCO Medical Solutions
11.15 Mitsubishi Electric Corporation
11.16 Brainlab AG
11.17 RaySearch Laboratories AB
11.18 Elekta AB
11.19 Nanobiotix

List of Tables
Table 1 Global Radiotherapy Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
Table 3 Global Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
Table 4 Global Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
Table 5 Global Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
Table 6 Global Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
Table 7 Global Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
Table 8 Global Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
Table 9 Global Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
Table 10 Global Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
Table 11 Global Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
Table 12 Global Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
Table 13 Global Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
Table 14 Global Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
Table 15 Global Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
Table 16 Global Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
Table 17 Global Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
Table 18 Global Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
Table 19 Global Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
Table 20 Global Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
Table 21 Global Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
Table 22 Global Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
Table 23 Global Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
Table 24 Global Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
Table 25 Global Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
Table 26 Global Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
Table 27 Global Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
Table 28 Global Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
Table 29 Global Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
Table 30 Global Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
Table 31 Global Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
Table 32 Global Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
Table 33 Global Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
Table 34 Global Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 35 Global Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 36 Global Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 37 Global Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
Table 38 Global Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 39 Global Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
Table 40 Global Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
Table 41 Global Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
Table 42 Global Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 43 Global Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
Table 44 North America Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
Table 45 North America Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
Table 46 North America Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
Table 47 North America Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
Table 48 North America Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
Table 49 North America Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
Table 50 North America Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
Table 51 North America Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
Table 52 North America Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
Table 53 North America Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
Table 54 North America Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
Table 55 North America Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
Table 56 North America Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
Table 57 North America Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
Table 58 North America Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
Table 59 North America Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
Table 60 North America Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
Table 61 North America Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
Table 62 North America Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
Table 63 North America Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
Table 64 North America Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
Table 65 North America Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
Table 66 North America Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
Table 67 North America Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
Table 68 North America Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
Table 69 North America Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
Table 70 North America Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
Table 71 North America Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
Table 72 North America Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
Table 73 North America Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
Table 74 North America Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
Table 75 North America Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
Table 76 North America Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
Table 77 North America Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 78 North America Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 79 North America Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 80 North America Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
Table 81 North America Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 82 North America Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
Table 83 North America Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
Table 84 North America Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
Table 85 North America Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 86 North America Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
Table 87 Europe Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
Table 88 Europe Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
Table 89 Europe Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
Table 90 Europe Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
Table 91 Europe Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
Table 92 Europe Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
Table 93 Europe Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
Table 94 Europe Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
Table 95 Europe Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
Table 96 Europe Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
Table 97 Europe Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
Table 98 Europe Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
Table 99 Europe Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
Table 100 Europe Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
Table 101 Europe Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
Table 102 Europe Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
Table 103 Europe Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
Table 104 Europe Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
Table 105 Europe Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
Table 106 Europe Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
Table 107 Europe Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
Table 108 Europe Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
Table 109 Europe Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
Table 110 Europe Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
Table 111 Europe Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
Table 112 Europe Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
Table 113 Europe Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
Table 114 Europe Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
Table 115 Europe Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
Table 116 Europe Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
Table 117 Europe Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
Table 118 Europe Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
Table 119 Europe Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
Table 120 Europe Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 121 Europe Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 122 Europe Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 123 Europe Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
Table 124 Europe Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 125 Europe Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
Table 126 Europe Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
Table 127 Europe Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
Table 128 Europe Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 129 Europe Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
Table 130 Asia Pacific Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
Table 131 Asia Pacific Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
Table 132 Asia Pacific Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
Table 133 Asia Pacific Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
Table 134 Asia Pacific Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
Table 135 Asia Pacific Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
Table 136 Asia Pacific Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
Table 137 Asia Pacific Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
Table 138 Asia Pacific Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
Table 139 Asia Pacific Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
Table 140 Asia Pacific Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
Table 141 Asia Pacific Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
Table 142 Asia Pacific Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
Table 143 Asia Pacific Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
Table 144 Asia Pacific Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
Table 145 Asia Pacific Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
Table 146 Asia Pacific Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
Table 147 Asia Pacific Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
Table 148 Asia Pacific Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
Table 149 Asia Pacific Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
Table 150 Asia Pacific Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
Table 151 Asia Pacific Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
Table 152 Asia Pacific Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
Table 153 Asia Pacific Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
Table 154 Asia Pacific Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
Table 155 Asia Pacific Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
Table 156 Asia Pacific Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
Table 157 Asia Pacific Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
Table 158 Asia Pacific Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
Table 159 Asia Pacific Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
Table 160 Asia Pacific Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
Table 161 Asia Pacific Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
Table 162 Asia Pacific Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
Table 163 Asia Pacific Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 164 Asia Pacific Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 165 Asia Pacific Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 166 Asia Pacific Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
Table 167 Asia Pacific Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 168 Asia Pacific Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
Table 169 Asia Pacific Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
Table 170 Asia Pacific Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
Table 171 Asia Pacific Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 172 Asia Pacific Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)
Table 173 Rest of the World Radiotherapy Market Outlook, By Country (2013-2022) ($MN)
Table 174 Rest of the World Radiotherapy Market Outlook, By Equipment (2013-2022) ($MN)
Table 175 Rest of the World Radiotherapy Market Outlook, By Linear Accelerators (2013-2022) ($MN)
Table 176 Rest of the World Radiotherapy Market Outlook, By Treatment Planning Systems (2013-2022) ($MN)
Table 177 Rest of the World Radiotherapy Market Outlook, By Radiation Therapy Simulators (2013-2022) ($MN)
Table 178 Rest of the World Radiotherapy Market Outlook, By Technology (2013-2022) ($MN)
Table 179 Rest of the World Radiotherapy Market Outlook, By Internal radiation therapy (2013-2022) ($MN)
Table 180 Rest of the World Radiotherapy Market Outlook, By High Dose Rate Radiotherapy (2013-2022) ($MN)
Table 181 Rest of the World Radiotherapy Market Outlook, By Low-Dose Rate Radiotherapy (2013-2022) ($MN)
Table 182 Rest of the World Radiotherapy Market Outlook, By Systemic radiation therapy (2013-2022) ($MN)
Table 183 Rest of the World Radiotherapy Market Outlook, By External Beam Radiation Therapy (2013-2022) ($MN)
Table 184 Rest of the World Radiotherapy Market Outlook, By Stereotactic body radiation therapy (2013-2022) ($MN)
Table 185 Rest of the World Radiotherapy Market Outlook, By Intensity-modulated radiation therapy (IMRT) (2013-2022) ($MN)
Table 186 Rest of the World Radiotherapy Market Outlook, By 3D-Conformal Radiotherapy (3D-CRT) (2013-2022) ($MN)
Table 187 Rest of the World Radiotherapy Market Outlook, By Tomotherapy (2013-2022) ($MN)
Table 188 Rest of the World Radiotherapy Market Outlook, By Volumetric Modulated ARC Therapy (2013-2022) ($MN)
Table 189 Rest of the World Radiotherapy Market Outlook, By Image-guided radiation therapy (IGRT) (2013-2022) ($MN)
Table 190 Rest of the World Radiotherapy Market Outlook, By Proton Beam therapy (2013-2022) ($MN)
Table 191 Rest of the World Radiotherapy Market Outlook, By Stereotactic radiosurgery (2013-2022) ($MN)
Table 192 Rest of the World Radiotherapy Market Outlook, By Product Type (2013-2022) ($MN)
Table 193 Rest of the World Radiotherapy Market Outlook, By Electron Beams (2013-2022) ($MN)
Table 194 Rest of the World Radiotherapy Market Outlook, By Non-Ionizing Radiation (2013-2022) ($MN)
Table 195 Rest of the World Radiotherapy Market Outlook, By Photon Radiations (2013-2022) ($MN)
Table 196 Rest of the World Radiotherapy Market Outlook, By Ionizing Radiation (2013-2022) ($MN)
Table 197 Rest of the World Radiotherapy Market Outlook, By Alpha and Beta Particles (2013-2022) ($MN)
Table 198 Rest of the World Radiotherapy Market Outlook, By Particle Radiation (2013-2022) ($MN)
Table 199 Rest of the World Radiotherapy Market Outlook, By Neutron Beams (2013-2022) ($MN)
Table 200 Rest of the World Radiotherapy Market Outlook, By Gamma Rays (2013-2022) ($MN)
Table 201 Rest of the World Radiotherapy Market Outlook, By X-rays (2013-2022) ($MN)
Table 202 Rest of the World Radiotherapy Market Outlook, By Proton Beams (2013-2022) ($MN)
Table 203 Rest of the World Radiotherapy Market Outlook, By Carbon Ions (2013-2022) ($MN)
Table 204 Rest of the World Radiotherapy Market Outlook, By Application (2013-2022) ($MN)
Table 205 Rest of the World Radiotherapy Market Outlook, By Head and Neck Cancer (2013-2022) ($MN)
Table 206 Rest of the World Radiotherapy Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 207 Rest of the World Radiotherapy Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 208 Rest of the World Radiotherapy Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 209 Rest of the World Radiotherapy Market Outlook, By Spine Cancer (2013-2022) ($MN)
Table 210 Rest of the World Radiotherapy Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 211 Rest of the World Radiotherapy Market Outlook, By Penile Cancer (2013-2022) ($MN)
Table 212 Rest of the World Radiotherapy Market Outlook, By Gynaecological Cancer (2013-2022) ($MN)
Table 213 Rest of the World Radiotherapy Market Outlook, By Skin & Lip Cancer (2013-2022) ($MN)
Table 214 Rest of the World Radiotherapy Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 215 Rest of the World Radiotherapy Market Outlook, By Other Applications (2013-2022) ($MN)



【レポートのキーワード】

内照射療法、全身放射線療法、体外照射療法

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[放射線療法の世界市場見通し2016-2022]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月03日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆